GH
Guardant Health, Inc.
Latest Form 4:Sale$6.3MbyTalasaz AmirAli (Co-Chief Executive Officer) · filed Aug 24, 2026
Guardant Health, Inc. (GH) has 169 SEC Form 4 filings (471 transaction rows) in the rolling window, disclosed by 14 distinct insiders. Most recent filing: Aug 27, 2026.
The most active filer is Director Tariq Musa with 11 filings. Insiders have net sold $123.7M over the trailing 6 months.
- Industry:Medical - Diagnostics & Research
- CEO:Helmy Eltoukhy
- Employees:1,999
- HQ:Palo Alto, CA, US
- IPO:2018-10-04
Insider Buying
$78K
reported purchases (SEC code P)
Insider Selling
$183.3M
reported sales (SEC code S)
Unique Insiders
14
in the rolling window
Market Cap
$21.7B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Co-Chief Executive Officer | Sale | 37,500 | $6.3M | Aug 24 | SEC ↗ | |
| Director | Sale | 116 | $18K | Aug 18 | SEC ↗ | |
Monroe Terilyn J.First in 4 months | Chief People Officer | Sale | 46,300 | $7.6M | Aug 13 | SEC ↗ |
| Chief Commercial Officer | Sale | 63,605 | $10.8M | Aug 11 | SEC ↗ | |
| Director | Sale | 1,700 | $279K | Aug 6 | SEC ↗ | |
| Director | Sale | 14,180 | $2.3M | Aug 5 | SEC ↗ | |
| Director | Sale | 116 | $19K | Jul 16 | SEC ↗ | |
| Chief Information Officer | Sale | 5,600 | $731K | Jun 30 | SEC ↗ | |
| Chief Information Officer | Purchase | 600 | $78K | Jun 30 | SEC ↗ | |
| Chief Information Officer | Sale | 600 | $79K | Jun 30 | SEC ↗ | |
| Co-Chief Executive Officer | Sale | 116,972 | $17.6M | Jun 30 | SEC ↗ | |
| Co-Chief Executive Officer | Sale | 143,028 | $21.7M | Jun 30 | SEC ↗ | |
POTTER MYRTLE SFirst in 8 months | Director | Sale | 1,556 | $204K | Jun 23 | SEC ↗ |
| Director | Sale | 1,951 | $256K | Jun 23 | SEC ↗ | |
| Director | Sale | 116 | $15K | Jun 16 | SEC ↗ | |
| Chief Information Officer | Sale | 3,418 | $445K | Jun 15 | SEC ↗ | |
Eltoukhy HelmyFirst in 6 months | Co-Chief Executive Officer | Sale | 100,000 | $12.6M | Jun 8 | SEC ↗ |
| Chief Financial Officer | Sale | 2,000 | $257K | Jun 8 | SEC ↗ | |
Krognes Steve E.First filing | Director | Sale | 9,294 | $1.2M | Jun 5 | SEC ↗ |
Joyce Meghan V.First in 9 months | Director | Sale | 10,000 | $1.3M | Jun 4 | SEC ↗ |
| Director | Sale | 1,000 | $130K | May 29 | SEC ↗ | |
| Chief Legal Officer | Sale | 10,000 | $1.3M | May 28 | SEC ↗ | |
Freeman ChrisFirst in 6 months | Chief Commercial Officer | Sale | 24,406 | $2.9M | May 26 | SEC ↗ |
Saia John G.First in 6 months | Chief Legal Officer | Sale | 20,000 | $2.1M | May 22 | SEC ↗ |
| Co-Chief Executive Officer | Sale | 210,000 | $23.1M | May 22 | SEC ↗ | |
CLARK IAN TFirst in 5 months | Director | Sale | 6,876 | $735K | May 22 | SEC ↗ |
| Director | Sale | 1,250 | $134K | May 22 | SEC ↗ | |
| Director | Sale | 116 | $11K | May 19 | SEC ↗ | |
Talasaz AmirAliFirst in 5 months | Co-Chief Executive Officer | Sale | 50,000 | $5.0M | May 13 | SEC ↗ |
| Director | Sale | 116 | $10K | Apr 16 | SEC ↗ | |
| Chief People Officer | Sale | 3,832 | $355K | Apr 7 | SEC ↗ | |
Tariq MusaFirst in 3 months | Director | Sale | 348 | $31K | Mar 19 | SEC ↗ |
Bell Michael BrianFirst in 3 months | Chief Financial Officer | Sale | 3,000 | $261K | Mar 17 | SEC ↗ |
| Director | Sale | 1,300 | $119K | Mar 9 | SEC ↗ | |
| Chief Information Officer | Sale | 40,000 | $3.8M | Mar 5 | SEC ↗ | |
| Chief People Officer | Sale | 8,571 | $978K | Jan 22 | SEC ↗ | |
| Chief People Officer | Sale | 10,031 | $1.1M | Jan 9 | SEC ↗ | |
| Director | Sale | 116 | $12K | Dec 18 | SEC ↗ | |
| Chief Technology Officer | Sale | 5,451 | $567K | Dec 17 | SEC ↗ | |
Eltoukhy HelmyFirst in 3 months | Co-Chief Executive Officer | Sale | 90,565 | $9.4M | Dec 17 | SEC ↗ |
Talasaz AmirAliFirst filing | Co-Chief Executive Officer | Sale | 50,000 | $5.3M | Dec 10 | SEC ↗ |
| Director | Sale | 1,250 | $131K | Dec 10 | SEC ↗ | |
Chudova DaryaFirst filing | Chief Technology Officer | Sale | 22,935 | $2.4M | Dec 10 | SEC ↗ |
Kalia KumudFirst filing | Chief Information Officer | Sale | 2,000 | $209K | Dec 10 | SEC ↗ |
Bell Michael BrianFirst filing | Chief Financial Officer | Sale | 80,362 | $8.3M | Dec 8 | SEC ↗ |
Freeman ChrisFirst filing | Chief Commercial Officer | Sale | 31,452 | $3.2M | Dec 8 | SEC ↗ |
CLARK IAN TFirst filing | Director | Sale | 28,611 | $3.1M | Dec 8 | SEC ↗ |
Monroe Terilyn J.First filing | Chief People Officer | Sale | 55,167 | $5.8M | Dec 3 | SEC ↗ |
| Director | Sale | 116 | $11K | Nov 20 | SEC ↗ | |
| Director | Sale | 1,500 | $143K | Nov 10 | SEC ↗ | |
Saia John G.First filing | Chief Legal Officer | Sale | 8,996 | $866K | Nov 10 | SEC ↗ |
| Director | Sale | 26 | $2K | Oct 20 | SEC ↗ | |
| Director | Sale | 116 | $8K | Oct 20 | SEC ↗ | |
POTTER MYRTLE SFirst filing | Director | Sale | 26 | $1K | Sep 17 | SEC ↗ |
Tariq MusaFirst filing | Director | Sale | 116 | $6K | Sep 17 | SEC ↗ |
Hidalgo Medina ManuelFirst filing | Director | Sale | 2,165 | $117K | Sep 15 | SEC ↗ |
Eltoukhy HelmyFirst filing | Co-Chief Executive Officer | Sale | 300,000 | $17.8M | Sep 11 | SEC ↗ |
Joyce Meghan V.First filing | Director | Sale | 100 | $7K | Sep 3 | SEC ↗ |
Related companies
Guardant Health, Inc. is in the Healthcare sector.